Nara Organics

nara.com →

-80%

est. 2Y upside i

Series A

The only USDA organic certified whole milk baby formula with no skim milk.

Rank

#3668

Sector

Food & Beverage, Infant Nutrition

Est. Liquidity

~4Y

Data Quality

Data: Medium

Nara Organics presents a risky equity opportunity with an estimated 9.5% expected upside over a two-year horizon.

Last updated: March 10, 2026

Bull (15%)+200%

Nara Organics leverages its unique FDA-registered and USDA-certified organic whole milk formula, strong brand, and successful Target distribution (exceeding sales forecasts by 110%) to capture a significant portion of the rapidly growing $7.4B SAM, achieving a $336M valuation (3x current) by expanding into new retail channels and product lines within two years.

Base (40%)+50%

Nara Organics maintains its position in the premium organic whole milk formula market, growing steadily through D2C and existing retail partnerships, but faces ongoing competitive pressure from established organic rivals. This leads to a $168M valuation (1.5x current) as it competes for market share.

Bear (45%)-90%

Intense competition from dominant legacy players and well-funded organic brands like Bobbie and Kendamil, coupled with high capital requirements and a severe $75M liquidation preference stack, restricts Nara Organics' growth. This results in an exit at or below invested capital, leading to a -90% downside for common stock holders.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

67%

Investors hold $75M in liquidation preferences ahead of common stock, meaning common shareholders would only see returns on the $37M difference ($112M - $75M) at the current valuation.

Dilution Risk

high

As a Series A2 company with high capital intensity, Nara Organics will likely require additional significant funding rounds, leading to further dilution for existing equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Nara Organics' equity.

Questions to Ask at the Interview

Strategic questions based on Nara Organics's data — designed to show you've done your homework.

  • 1

    “Nara Organics has achieved significant distribution with Target and reported sales 110% above forecast through this channel. How is the company planning to sustain this rapid growth and expand its market penetration beyond initial retail success, especially given the strong presence of established organic competitors like Bobbie and Kendamil?”

  • 2

    “The organic infant formula market is projected for strong growth, but the overall infant formula market has a lower CAGR. How does Nara Organics plan to navigate potential pricing pressures or market shifts from larger, diversified incumbents like Nestlé or Abbott, who might increase their focus on the premium organic segment?”

  • 3

    “Given the Series A2 funding round in late 2025 and the high capital intensity of the business, what is the anticipated timeline for future funding rounds or a potential liquidity event, and how does the company envision employee equity evolving through these stages, especially considering the current preference stack?”

Community

Valuation Sentiment

Our model estimates -80% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.